Clinical course of patients with rheumatoid arthritis who continue or discontinue biologic therapy after hospitalization for infection: a retrospective observational study.

Yusuke KashiwadoChikako KiyoharaYasutaka KimotoShuji NaganoTakuya SawabeKensuke OryojiShinichi MizukiHiroaki NishizakaSeiji YoshizawaShigeru YoshizawaTomomi TsuruYasushi InoueNaoyasu UedaShun-Ichiro OtaYasuo SuenagaTomoya MiyamuraYoshifumi TadaHiroaki NiiroKoichi AkashiTakahiko Horiuchi

Published in: Arthritis research & therapy (2022)

Discontinuation of biologic therapy after hospitalization for infections may result in RA flares. Continuation of biologic therapy is preferable, particularly in patients without immunodeficiency.

Keyphrases

prognostic factors
rheumatoid arthritis
stem cells
chronic kidney disease
end stage renal disease
ejection fraction
newly diagnosed
mesenchymal stem cells
ankylosing spondylitis
cell therapy
interstitial lung disease
idiopathic pulmonary fibrosis
smoking cessation